Table 2.

Antibodies Used in This Study

NoShift assay
Anti‐CREB1	sc‐58; Santa Cruz Biotechnology, Santa Cruz, CA
Anti‐NR4A1 (NGFI‐B)	CBX00289; Cosmo Biolabs Inc, Tokyo, Japan
Anti‐NR4A2 (NURR1)	sc‐991; Santa Cruz Biotechnology
Anti‐NR4A3 (NOR1)	PP‐H7833‐00; Perseus Proteomics Inc, Tokyo, Japan
Anti‐NR5A1 (SF1)	A generous gift of Dr Ken‐ichiro Morohashi
Anti‐MECP2	pAb‐052‐050; Diagenode sa, Liège, Belgium
Chromatin immunoprecipitation quantitative PCR
Anti‐MECP2	pAb‐052‐050; Diagenode sa
Anti‐MBD1	ab2846; Abcam, Cambridge, UK
Anti‐MBD2	A‐1007; Epigentek Group Inc, Brooklyn, NY
Anti‐CREB1	sc‐240; Santa Cruz Biotechnology
Anti‐phospho‐CREB1 (Ser133)	#17‐10131; Millipore, Billerica, MA
Anti‐NR4A1 (NGFI‐B)	ab13851; Abcam

CREB1 indicates cAMP response element binding protein1; MBD, methyl‐CpG‐binding domain protein; MECP, methyl‐CpG binding protein; NGFI‐B, nerve growth factor‐induced clone B; NOR1, neuron‐derived orphan receptor 1; NURR1, NUR‐related factor 1; SF1, steroidogenic factor 1.